Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
Ciclesonide is a novel inhaled corticosteroid for the treatment of asthma. In this study the
effect of ciclesonide on airway hyperresponsiveness (AHR), exhaled nitric oxide (NO), and
induced sputum inflammatory biomarkers will be evaluated.